Analisis Kinerja Keuangan Sektor Farmasi Yang Terdaftar Di BEI Sebelum Dan Saat Covid-19
Article Sidebar
Profitability ratio,
Covid-19,
IDX,
Financial Performance
Main Article Content
Abstract
Financial performance is a reference that the company wants to achieve in the future within a certain period of time, which effectively and efficiently reflects the health of the company. This study aims to obtain information on the financial performance of pharmaceutical sector companies listed on the IDX before and during COVID-19. The research method used in this research is descriptive quantitative. The data analysis technique used is the profitability ratio with secondary data collection. The results of the analysis show that COVID-19 affects the financial performance of pharmaceutical sector companies listed on the Indonesia Stock Exchange. There are several companies experiencing an increase in profitability ratios before and during COVID-19, but not significantly. This supports the agency theory and the signal theory that management has managed the company effectively so that there is an increase in profits. A high profitability ratio is a good signal for investors to invest their shares in the company so that the value of the company's shares will rise.
Article Details
References
Ayuningtyas, F. D. (2019). Analisis rasio profitabilitas untuk menilai kinerja keuangan (studi kasus pada industri farmasi yang terdaftar di Bursa Efek Indonesia tahun 2015-2018). IAIN Purwokerto.
Barus, M. A., Sudjana, N., & Sulasmiyati, S. (2017). Penggunaan rasio keuangan untuk mengukur kinerja keuangan perusahaan (studi pada PT. Astra Otoparts, Tbk dan PT. Goodyer Indonesia, Tbk yang go public di bursa efek indonesia). Jurnal Administrasi Bisnis S1 Universitas Brawijaya, 44(1).
Basdekis, C., Christopoulos, A., Katsampoxakis, I., & Lyras, A. (2020). Profitability and optimal debt ratio of the automobiles and parts sector in the Euro area. Journal of Capital Markets Studies. https://doi.org/https://doi.org/10.1108/jcms-08-2020-0031
Chhapare, S., & Bhutada, R. S. (2020). International journal of research in pharmaceutical sciences.
Faruk, H., & Habib, A. (2010). Performance evaluation and ratio analysis of Pharmaceutical Company in Bangladesh.
Fitra, S. (2020). Industri Farmasi di Tengah Pandemi, Untung atau Buntung? https://katadata.co.id/safrezifitra/finansial/5f7c09e484bf8/industri-farmasi-di-tengah-pandemi-untung-atau-buntung
Gitman, L., & Chad, Z. (2012). Principles of managerial finance (Global Edi). Person Education Limited.
Jatmiko, A. (2020). Kebal pandemi, laba tiga perusahaan farmasi semester I naik signifikan. https://katadata.co.id/agungjatmiko/finansial/5f325299a3b35/kebal-pandemi-laba-tiga-perusahaan-farmasi-semester-i-naik-signifikan#:~:text=Korporasi-,Kebal Pandemi%2C Laba Tiga Perusahaan Farmasi Semester I Naik Signifikan,suplemen di tengah pandemi corona.
Kasmir. (2016). Analisis laporan keuangan. Jakarta : PT. Raja Grafindo Persada.
Limbong, G. (2022). Analysis of the company’s financial performance before and during The Covid-19 Pandemic (2019-2020) in pharmaceutical sector companies listed on The Idx. Jurnal Manajemen, 10(2).
Pongoh, M. (2013). Analisis laporan keuangan untuk menilai kinerja keuangan PT. Bumi Resources Tbk. Jurnal EMBA: Jurnal Riset Ekonomi, Manajemen, Bisnis Dan Akuntansi, 1(3).
Rosyadah, F. (2013). Pengaruh struktur modal terhadap profitabilitas (Studi pada perusahaan real estate and property yang terdaftar di Bursa Efek Indonesia (BEI) Periode 2009–2011). Brawijaya University.
Sofyan, M. (2019). Rasio keuangan untuk menilai kinerja keuangan. Akademika, 17(2), 115–121.
Sudana, I. M. (2015). Manajemen keuangan perusahaan (Edisi 2). Jakarta: Erlangga.
Yasmin, Y., & Fuadati, S. R. (2017). Analisis rasio keuangan untuk menilai kinerja keuangan Perusahaan Farmasi di BEI. Jurnal Ilmu Dan Riset Manajemen (JIRM), 6(2).